Tuesday marks the first day of spring! Is the Biotech winter thawing? Promising signs exist for the days ahead. Importantly, what did the past year teach us? Auxilius is pleased to share our Annual Report - a reflection of learnings, industry observations and expected trends. https://lnkd.in/dWzsKN9E #biotech #clinicaltrials #pharma #financeandaccounting
Auxilius
Software Development
New York, NY 10,161 followers
Clinical Trial Financial Management Software for Biopharma
About us
Auxilius is a data-driven, clinical trial financial management platform. We help Biotechs take control over trial costs, manage financial risk, and optimize spend in pursuit of trial targets. It’s time to make financial management part of the cure.
- Website
-
https://www.auxili.us
External link for Auxilius
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Clinical Trial Financial Management, Accounting, Finance, Clinical Trials, FP&A, and SaaS
Locations
-
Primary
New York, NY, US
Employees at Auxilius
Updates
-
Controls and SOX compliance surrounding outsourced R&D/Clinical spend is necessary for today's biopharma companies. Crowe and Auxilius teamed up recently for a substantive webinar on the key issues driving critical audit matters, regulatory risk and operational efficiency in clinical trial financial management. Tune-in here for practical considerations on to how to mitigate risk throughout your clinical trial processes. https://lnkd.in/d8CekwGV
2024 GRC Webinar Series: How to mitigate critical risks in your clinical trial processes
event.on24.com
-
Please join Auxilius and Crowe this Thursday, April 25, from 1-2p EST for a CPE-accredited webinar. Part of Crowe's 2024 GRC Webinar Series, this session examines ways to mitigate risks associated with clinical trial processes. https://lnkd.in/eUQsupWg
-
As 2024 is underway, the life science sector faces great growth opportunity along with new industry norms. Products are on the precipice for commercial launch, organizations must stay judicious in capital allocation, and teams face new demands for resource efficiency - specifically around R&D spend and clinical accruals. Auxilius summarizes some observed trends here - check it out! https://hubs.li/Q02nlzs70
-
Immersed in year-end wrap-up and 10K review/audit? Auxilius understands the materiality and complexity of R&D spend reporting and clinical accruals. Join us February 15 for a webinar showcasing how today's biopharma companies are streamlining the end-to-end process for this major cost category. Register now to secure your spot: https://lnkd.in/ebdA6uf8. We would love to see you there!
Product Demo: Strategies to Forecast and Accrue for Investigator Spend
auxili.us
-
Amongst other takeaways, 2023 has been a year of process consciousness for R&D spend and clinical trial financial management - typically the biggest and most complex cost category. Across the industry (private/emerging growth biotech to mature large MNL pharma) there has been a sea shift in focus towards process improvement along with a drop in tolerance for inefficiency and inaccuracy. Auxilius is happy to share some reflective questions as companies embark on their own housekeeping and improvement journey + observations around the rising bar in accrual financial management and close best practices. https://hubs.li/Q02dqK2v0
Financial Close Processes for Clinical Trials - What is Gold Standard?
notes.auxili.us
-
Great rundown on IPO readiness from Deloitte, with translatable takeaways for private/public-aspiring biotechs: "Getting your house in order" means... * Implement key systems * Streamline the close process * Make sure company forecasts and projections are bulletproof The life science sector's R&D intensity has increased. Investment in clinical trials is highly 3rd party outsourced, financially material, complex and vulnerable to kinetic change. Great point of consideration for private companies to aim for a bulletproof forecast on this large line item! https://lnkd.in/eJyxVTYH
IPO Readiness: Is the Market Opening for Tech?
www2.deloitte.com
-
Given the risk exposure and materiality of R&D spend and clinical trial accruals, Auxilius is pleased to partner with Deloitte on an upcoming webinar in advance of year end reporting. Join your biotech finance and accounting peers as we discuss key considerations for audit readiness and operational efficiency around clinical trial financial management. https://hubs.li/Q02bmRvc0
Deloitte & Auxilius Webinar: Ensure Audit-Readiness and Operational Efficiency for R&D Accruals and Clinical Trial Financial Reporting
auxili.us
-
Barometer check - good time to measure against industry trends, challenges, commonalities and new standards of practice. Pleased to share Auxilius' most recent fall Industry Benchmarking Report, which calls out some of the common themes, macroeconomic issues and initiatives underway amongst your peer set. There is a new standard for clinical trial financial/accounting management, and we would love to share that with you! https://lnkd.in/ewPXitCN
Bioscience Finance & Accounting Insights and Benchmarking Report
auxili.us
-
Can you relate to the 95% of biotech companies (based on a recent industry survey) experiencing challenges in estimating R&D accruals? Interested in joining your peers to learn how to streamline financial reporting processes via data analytics and automation? Please join us for an educational webinar on November 9th as we tackle these challenges with proven solutions and strategies. https://hubs.li/Q026Tnjd0